Related Experiment Video
Updated: Jul 15, 2026

A Novel Approach for Documenting Phosphenes Induced by Transcranial Magnetic Stimulation
Published on: April 1, 2010
Scophedal (SEE) was it a fad or a miracle drug?
Ray J Defalque1, Amos J Wright
1Department of Anesthesiology, University of Alabama at Birmingham, USA.
Abstract:
The German firm E. Merck released in 1928, an injectable mixture of scopolamine, oxycodone, and ephedrine under the name SEE. This drug, renamed Scophedal in 1942 caused deep and prolonged analgesia, sedation, euphoria and amnesia without significant respiratory or circulatory depression. Used extensively by the German and Central European surgeons in the 1930s, Scophedal enjoyed immense popularity with the Wehrmacht's medical officers treating frontline mass casualties during World War II. The use of Scophedal declined after 1945, and its production was discontinued in 1987. Despite the clinical enthusiasm it raised, SEE was never critically investigated. This drug may deserve a rigorous re-evaluation.
Related Concept Videos
Drug Regulation
CNS Stimulants: Psychedelic Agents
The Placebo Effect
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
